Mirati Therapeutics Inc (DELISTED) (MRTX:DL)
58.70
0.00 (0.00%)
USD |
NASDAQ |
Jan 23, 16:00
Mirati Therapeutics Profit Margin (Quarterly): -987.2% for Sept. 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -987.2% |
| June 30, 2023 | -1.29K% |
| March 31, 2023 | -2.58K% |
| December 31, 2022 | -21.68K% |
| September 30, 2022 | -3.20K% |
| June 30, 2022 | -3.29K% |
| March 31, 2022 | -26.57K% |
| December 31, 2021 | -66.76K% |
| September 30, 2021 | -111.5% |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -5.95K% |
| September 30, 2020 | -771.7% |
| June 30, 2020 | |
| March 31, 2020 | -32.46K% |
| December 31, 2019 | -13.76K% |
| September 30, 2019 | -5.48K% |
| June 30, 2019 | -7.89K% |
| March 31, 2019 | -3.28K% |
| December 31, 2018 | -816.3% |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | -158.4% |
| December 31, 2017 | |
| September 30, 2017 |
| Date | Value |
|---|---|
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | -725.9% |
| September 30, 2011 | -4.60K% |
| June 30, 2011 | -115.5% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-66.76K%
Minimum
Dec 2021
-111.5%
Maximum
Sep 2021
-13.80K%
Average
-3.29K%
Median
Jun 2022
Profit Margin (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 10.18% |
| Karuna Therapeutics Inc (DELISTED) | -- |
| Puma Biotechnology Inc | -9.62% |
| NovaBay Pharmaceuticals Inc | -66.04% |
| Palatin Technologies Inc | -2.36K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -77.82% |
| Return on Assets | -64.99% |
| Return on Invested Capital | -77.82% |
| Gross Profit Margin (Quarterly) | 89.71% |
| Operating Margin (Quarterly) | -1.05K% |
| Return on Net Operating Assets | -483.2% |